Evaluation of the CYP2D6 Haplotype Activity Scores Based on Metabolic Ratios of 4,700 Patients Treated With Three Different CYP2D6 Substrates.

Summary

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Jukić MM, Smith RL, Molden E, Ingelman-Sundberg M.

Journal title: Clinical pharmacology and therapeutics

Journal publisher: Nature Publishing Group

Published year: 2021

DOI identifier: 10.1002/cpt.2246

ISSN: 0009-9236